Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar Haugurafpeningum (85.94) Submitted: 11/8/2011 2:36:09 AM : Outperform Start Price: $3.29 SVNT Score: -77.97

Technical Monthly

Featured Broker Partners


Advertisement